Abstract
BL-S 339 is a new broad-spectrum, parenterally effective cephalosporin whose expression of antibacterial activity in vitro is markedly affected by the nature of the assay medium. When assayed in nutrient agar, BL-S 339 was more active than cephalothin against strains of Diplococcus pneumoniae, Streptococcus pyogenes, Escherichia coli, Serratia marcescens, Klebsiella pneumoniae, Enterobacter, and indole-positive Proteus sp. However, when assayed in Mueller-Hinton medium, its activity, especially against gram-negative bacteria, was reduced substantially, whereas the activity of cephalothin was virtually unaffected by the assay medium. The in vivo activity of BL-S 339 correlated well with its activity in nutrient agar; when administered subcutaneously to mice, it was therapeutically more efficacious than cephalothin in infections caused by both gram-positive and gram-negative bacteria. When BL-S 339 was administered intramuscularly to mice, the concentrations achieved in the blood were three times those achieved with cephalothin. BL-S 339 was bound to human serum proteins to the same extent as cephalothin. Recovery of BL-S 339 in the urine within the 24-hr period after intramuscular administration to rats was three times that of cephalothin.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Price K. E., Bach J. A., Chisholm D. R., Misiek M., Gourevitch A. Preliminary microbiological and pharmacological evaluation of 6-(R-alpha-amino-3-thienylacetamido) penicillanic acid (BL-P 875). J Antibiot (Tokyo) 1969 Jan;22(1):1–11. doi: 10.7164/antibiotics.22.1. [DOI] [PubMed] [Google Scholar]
- SCHOLTAN W., SCHMID J. [The binding of penicillins on the proteins of the blood and tissues]. Arzneimittelforschung. 1962 Aug;12:741–750. [PubMed] [Google Scholar]